Automated description from the Alliance of Genome Resources (Release 7.5.0)
Predicted to enable SH2 domain binding activity; phosphatase binding activity; and sialic acid binding activity. Involved in several processes, including negative regulation of calcium-mediated signaling; negative regulation of inflammatory response to wounding; and regulation of B cell proliferation. Acts upstream of or within hematopoietic progenitor cell differentiation. Predicted to be active in plasma membrane. Is expressed in liver and thymus primordium. Orthologous to several human genes including SIGLEC10 (sialic acid binding Ig like lectin 10).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.